ZIVO Bioscience (ZIVO) Stock Price, News & Analysis

Company Overview

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

Key Stats

• Today's Range: $11.05 to $11.05
• 50-Day Range: $11.21 to $18.72
• 52-Week Range: $5.80 to $22.15
• Volume: 187 shs
• Average Volume: 957 shs
• Market Capitalization: $42.18 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ZIVO Stock Analysis - Frequently Asked Questions

How have ZIVO shares performed this year?

ZIVO Bioscience's stock was trading at $21.50 at the beginning of 2025. Since then, ZIVO shares have decreased by 48.6% and is now trading at $11.05.

How were ZIVO Bioscience's earnings last quarter?

ZIVO Bioscience, Inc. (NASDAQ:ZIVO) issued its quarterly earnings results on Monday, May, 11th. The biotechnology company reported ($0.06) EPS for the quarter. The biotechnology company earned $0.02 million during the quarter.

When did ZIVO Bioscience's stock split?

ZIVO Bioscience's stock reverse split before market open on Friday, October 27th 2023.The 1-6 reverse split was announced on Friday, October 27th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

How do I buy shares of ZIVO Bioscience?

Shares of ZIVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of ZIVO Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ZIVO Bioscience investors own include Canopy Growth (CGC), Meta Platforms (META), OPKO Health (OPK), Johnson & Johnson (JNJ), ACADIA Pharmaceuticals (ACAD), Aravive (ARAV) and Alibaba Group (BABA).

Company Calendar

• Last Earnings: 5/11/2020
• Today: 7/25/2025
• Next Earnings (Estimated): 8/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biological products, except diagnostic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ZIVO
• Previous Symbol: OTCMKTS:HEPI
• CIK: 1101026
• Web: www.zivobioscience.com
• Phone: (248) 452-9866
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($4.93)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$7.78 million
• Net Margins: N/A
• Pretax Margin: -17,113.75%
• Return on Equity: N/A
• Return on Assets: -2,240.92%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.17
• Quick Ratio: 0.17

Sales & Book Value

• Annual Sales: $15.85 thousand
• Price / Sales: 2,661.06
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.81) per share
• Price / Book: -13.64

Miscellaneous

• Outstanding Shares: 3,817,000
• Free Float: 2,911,000
• Market Cap: $42.18 million
• Optionable: Not Optionable
• Beta: -0.06